scispace - formally typeset
W

Weidong Fei

Researcher at Zhejiang University

Publications -  50
Citations -  822

Weidong Fei is an academic researcher from Zhejiang University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 11, co-authored 32 publications receiving 308 citations. Previous affiliations of Weidong Fei include Zhejiang Chinese Medical University.

Papers
More filters
Journal ArticleDOI

The role of short-chain fatty acids in immunity, inflammation and metabolism

TL;DR: Theoretical basis for the study of SCFAs as potential drugs to promote human health is provided, which provides a systematic theoretical basis for studying the potential role ofSCFAs in regulating energy homeostasis and metabolism.
Journal ArticleDOI

Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells.

TL;DR: A new one-pot reaction for the synthesis of manganese doped mesoporous silica nanoparticles (MMSNs) which could induce ferroptosis of the tumor cells through the consumption of intracellular GSH caused by the degradation of MMSNs is introduced.
Journal ArticleDOI

RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma

TL;DR: The strategy of constructing a nanocarrier with targeted delivery and controlled release characteristics is prospective to enhance the antitumor effect of ATO.
Journal ArticleDOI

Targeted GSH-exhausting and hydroxyl radical self-producing manganese–silica nanomissiles for MRI guided ferroptotic cancer therapy

TL;DR: F folate-PEG modified dihydroartemisinin (DHA) loaded manganese doped mesoporous silica nanoparticles (described as nanomissiles) were constructed and suppressed tumor metastasis by destroying the structure of polyunsaturated fatty acids in the cell membranes and showed potent antitumor activity.
Journal ArticleDOI

pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.

TL;DR: It is suggested that the polyacrylic acid capped mesoporous silica nanoparticles (PAA-MSN) will be a promising nanocarrier for improving pharmacokinetic features and enhancing the anti-tumor efficacy of arsenic trioxide.